TG Therapeutics (NASDAQ: TGTX) will release its quarterly earnings report on Monday, 2025-11-03. Here's a brief overview for investors ahead of the announcement. Analysts anticipate TG Therapeutics to ...
Shares of CleanSpark, Inc. (NASDAQ:CLSK) are trading higher Wednesday after the Bitcoin (CRYPTO: BTC) miner announced ...
A hospitalized patient triggers a major setback for Intellia's $1.9B flagship drug, shaking investor faith overnight ...
Vertex Pharmaceuticals Incorporated remains a leader in CF treatments, fueling robust cash flow and pipeline expansions.
Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.
Intellia Therapeutics will find it challenging to survive now that its CRISPR gene-editing treatment has been tied to severe, ...
Fermi’s stock fell below its IPO price last week but is bouncing back on positive comments from analysts and pacts with South ...
Intellia Therapeutics (NASDAQ:NTLA) stock tumbled 50% Monday after the company announced it has temporarily paused patient dosing and screening for its Phase 3 clinical trials of nex-z due to a ...
View Aeon Acquisition I Corp Class A AESP stock quote prices, financial information, real-time forecasts, and company news from CNN.
TipRanks on MSN
Crispr Therapeutics AG Faces Stock Price Slump
Read on to learn why.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest ...
CRISPR Therapeutics (CRSP) recently showcased new preclinical results for its CTX460 therapy, revealing strong gene and mRNA correction in animal models for Alpha-1 Antitrypsin Deficiency. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results